Extreme variant of the A110 will be strictly limited and priced well above the £90,000 A110 R
Alpine is preparing to send the A110 out on a high note with a stripped-out, track-focused variant to rival the Porsche Cayman GT4 RS. Developed with input from Alpine F1 driver Esteban Ocon, the climactic variant of the A110 is understood to be a strictly limited proposition priced well above the £90,000 A110 R; reputable enthusiast publication Les Alpinistes says just 110 examples will be built, starting from €250,000 .
It is reported that a gearbox swap will require the A110’s engine bay to be redesigned, but it is not confirmed how extensively the coupé’s structure has been revamped. Alpine is also targeting a kerb weight below 1000kg, giving the A110 a similar power-to-weight ratio as the Cayman GT4 RS, rated at 348bhp per tonne. Autocar understands Alpine’s ambition is to beat the GT4 RS’s Nürburgring lap time of 7min 4.51sec. In October, spy photographers clocked the A110 at 7min 18.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Living with a back-to-basics Alpine A110 sports car: the rare necessitiesCAR magazine UK's Alpine A110 long-term test: we live with a base-spec A110 sports car to reveal what it's really like as a Porsche 718 Cayman alternative
Read more »
Updated Alpine Alpenglow Concept To Lap Spa-Francorchamps Next MonthThe dramatic concept is powered by a combustion engine fueled by hydrogen
Read more »
Stocks making the biggest premarket moves: Nike, CarMax, Robinhood, Alpine Immune Sciences and moreThese are the stocks posting the largest moves in the premarket.
Read more »
Alpine hypercar concept to run hydrogen engine at SpaLe Mans may soon have a class for hydrogen-powered cars, and Alpine's Alpenglow concept may provide a clue of what a race car for the class will be like.
Read more »
Alpine to run hydrogen-combustion supercar at Spa next monthAlpenglow prototype aims to prove that hydrogen-fuelled engines can "enhance driving pleasure" tenfold
Read more »
Vertex Pharma bets on kidney disease treatment with $4.9 bln Alpine Immune dealVertex Pharmaceuticals will buy Alpine Immune Sciences for about $4.9 billion in cash, gaining access to the biotech firm's treatment for an autoimmune disease of the kidney, the companies said on Wednesday.
Read more »